MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Mycophenolic acid

Mycophenolic acid 180mg gastro-resistant tablets

Incompatible

Stability notes for Mycophenolic acid 180mg gastro-resistant tablets

Protect from light. Protect from moisture. Airtight container. Teratogenic.

Provenance

Compatiblity information derived from Myfortic 180mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (4) of Mycophenolic acid 180mg gastro-resistant tablets
Ceptava 180mg gastro-resistant tablets (Sandoz Ltd)
Mycophenolic acid 180mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Mycophenolic acid 180mg gastro-resistant tablets (Accord-UK Ltd)
Myfortic 180mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd)

Mycophenolic acid 360mg gastro-resistant tablets

Incompatible

Stability notes for Mycophenolic acid 360mg gastro-resistant tablets

Protect from light. Protect from moisture. Airtight container. Teratogenic.

Provenance

Compatibility information derived from Myfortic 360mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (4) of Mycophenolic acid 360mg gastro-resistant tablets
Ceptava 360mg gastro-resistant tablets (Sandoz Ltd)
Mycophenolic acid 360mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Mycophenolic acid 360mg gastro-resistant tablets (Accord-UK Ltd)
Myfortic 360mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.